Literature DB >> 21291853

Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum β-lactamase (ESBL) and non-ESBL producing Escherichia coli.

Chia-Jung Hsieh1, Yea-Huei Shen, Kao-Pin Hwang.   

Abstract

BACKGROUND/
PURPOSE: Infections caused by extended-spectrum β-lactamase (ESBL)-producing bacteria have become a serious clinical concern worldwide. The occurrence of ESBLs in Taiwan has been well-documented and is reviewed in recent publications. However, studies comparing community-onset bacteremia caused by ESBL- and non-ESBL-producing Escherichia coli are limited.
METHODS: We retrospectively reviewed the medical records of patients with E. coli bacteremia who visited the emergency department of Kaohsiung Chang Gung Memorial Hospital from January 2005 to December 2006. Clinical data were collected to compare the clinical features of patients with ESBL-producing E. coli with those of patients with non-ESBL-producers and to identify the risk factors associated with ESBL-producing E. coli bacteremia.
RESULTS: There were 404 episodes of community-onset E. coli bacteremia. The overall 30-day mortality rate was 11.4% (46/404) and the mortality rate of healthcare-associated infections was significantly higher than that of community-acquired infections [4/13 (30.8%) vs. 42/391 (10.7%); p= 0.049] Nonurinary focus was independently associated with an increased risk of fatality [47/178 (26.4%) vs. 4/226 (1.8%); p < 0.001]. The frequency of ESBL producers was 4.7% (19/404). Of these, four (21.1%) were associated with a long-term care facility. Significant risk factors associated with ESBL-producing E. coli bacteremia included recent antibiotic exposure (within 30 days) and urinary catheter placement. Although the trend was towards higher mortality in patients with ESBL-producing E. coli bacteremia, the difference did not reach statistical significance compared with the mortality of patients with non-ESBL E. coli bacteremia.
CONCLUSION: Fewer than 5% of community-onset E. coli bacteremia episodes in Southern Taiwan were due to ESBL-producers. Prior antibiotic use within 30 days and urinary catheter placement were independently associated with ESBL-producing E. coli bacteremia.
Copyright © 2010 Taiwan Society of Microbiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21291853     DOI: 10.1016/S1684-1182(10)60038-2

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  13 in total

1.  Establishment of a Simple and Quick Method for Detecting Extended-Spectrum β-Lactamase (ESBL) Genes in Bacteria.

Authors:  Song-Tao Han; Ying Fei; Jin-You Huang; Mei Xu; Li-Chan Chen; D Joshua Liao; Yu-Jie Tan
Journal:  J Biomol Tech       Date:  2016-09-16

2.  Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.

Authors:  Keyvan Razazi; Lennie P G Derde; Marine Verachten; Patrick Legrand; Philippe Lesprit; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2012-08-15       Impact factor: 17.440

3.  Clinical characteristics and therapeutic outcomes of nosocomial super-infection in adult bacterial meningitis.

Authors:  Chi-Ren Huang; Shu-Fang Chen; Cheng-Hsien Lu; Yao-Chung Chuang; Nai-Wen Tsai; Chiung-Chih Chang; Hung-Chen Wang; Chun-Chih Chien; Wen-Neng Chang
Journal:  BMC Infect Dis       Date:  2011-05-18       Impact factor: 3.090

4.  A simple scoring algorithm predicting extended-spectrum β-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: Matters of frequent emergency department users.

Authors:  Chung-Hsun Lee; Feng-Yuan Chu; Chih-Chia Hsieh; Ming-Yuan Hong; Chih-Hsien Chi; Wen-Chien Ko; Ching-Chi Lee
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Modifiable healthcare factors affecting 28-day survival in bloodstream infection: a prospective cohort study.

Authors:  Rebecca N Evans; Katie Pike; Chris A Rogers; Rosy Reynolds; Margaret Stoddart; Robin Howe; Mark Wilcox; Peter Wilson; F Kate Gould; Alasdair MacGowan
Journal:  BMC Infect Dis       Date:  2020-07-25       Impact factor: 3.090

6.  Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016.

Authors:  Tingting Xiao; Kai Yang; Yanzi Zhou; Shuntian Zhang; Jinru Ji; Chaoqun Ying; Ping Shen; Yonghong Xiao
Journal:  Antimicrob Resist Infect Control       Date:  2019-08-27       Impact factor: 4.887

7.  Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia.

Authors:  Jiun-Ling Wang; Ching-Chi Lee; Chung-Hsun Lee; Nan-Yao Lee; Chih-Chia Hsieh; Yuan-Pin Hung; Hung-Jen Tang; Wen-Chien Ko
Journal:  J Clin Med       Date:  2018-12-03       Impact factor: 4.241

8.  Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Patients with Liver Cirrhosis.

Authors:  Wen-Chi Chen; Chih-Hsin Hung; Yao-Shen Chen; Jin-Shiung Cheng; Susan Shin-Jung Lee; Fan-Chen Tseng; Ming-Fang Cheng; Jiun-Ling Wang
Journal:  Pathogens       Date:  2021-01-05

Review 9.  Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis.

Authors:  M C MacKinnon; J M Sargeant; D L Pearl; R J Reid-Smith; C A Carson; E J Parmley; S A McEwen
Journal:  Antimicrob Resist Infect Control       Date:  2020-12-10       Impact factor: 4.887

10.  Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing Escherichia coli infections.

Authors:  So Yeon Park; Cheol-In Kang; Yu Mi Wi; Doo Ryeon Chung; Kyong Ran Peck; Nam-Yong Lee; Jae-Hoon Song
Journal:  Korean J Intern Med       Date:  2016-04-20       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.